Clinical Trials Medtech - July 13, 2021
Chordate Medical receives CE mark approval
The company has received CE mark approval for a neuromodulation treatment of Chronic Migraine. The Swedish company’s existing EC-certificate for K.O.S has now been granted an extension with the indication Chronic Migraine and the intended use: Preventive treatment of chronic migraine in adults over 18 years. The CE marking means that the K.O.S treatment meets […]